286 related articles for article (PubMed ID: 30813787)
1. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
[TBL] [Abstract][Full Text] [Related]
2. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.
Mastboom MJ; Planje R; van de Sande MA
Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
[TBL] [Abstract][Full Text] [Related]
5. Management of tenosynovial giant cell tumour of the foot and ankle.
Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
[TBL] [Abstract][Full Text] [Related]
6. What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?
Yao L; Li Y; Li T; Fu W; Chen G; Li Q; Tang X; Li J; Xiong Y
Clin Orthop Relat Res; 2023 Dec; ():. PubMed ID: 38153106
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Advanced Tenosynovial Giant Cell Tumor of the Knee Diagnosed During Total Knee Arthroplasty.
Lei P; Sun R; Liu H; Zhu J; Wen T; Hu Y
J Arthroplasty; 2017 Jun; 32(6):1850-1855. PubMed ID: 28161138
[TBL] [Abstract][Full Text] [Related]
8. A New Simple and Practical Clinical Classification for Tenosynovial Giant Cell Tumors of the Knee.
Zheng K; Yu XC; Hu YC; Xu M; Zhang JY
Orthop Surg; 2022 Feb; 14(2):290-297. PubMed ID: 34914180
[TBL] [Abstract][Full Text] [Related]
9. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
[TBL] [Abstract][Full Text] [Related]
10. The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study.
Bernthal NM; Spierenburg G; Healey JH; Palmerini E; Bauer S; ; Gelderblom H; Staals EL; Lopez-Bastida J; Fronk EM; Ye X; Laeis P; van de Sande MAJ
Orphanet J Rare Dis; 2021 Apr; 16(1):191. PubMed ID: 33926503
[TBL] [Abstract][Full Text] [Related]
11. Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
Palmerini E; Healey JH; Bernthal NM; Bauer S; Schreuder H; Leithner A; Martin-Broto J; Gouin F; Lopez-Bastida J; Gelderblom H; Staals EL; Mercier F; Laeis P; Ye X; van de Sande M
Oncologist; 2023 Jun; 28(6):e425-e435. PubMed ID: 36869793
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR; Rudran B; Khan A; O'Reilly-Harbidge S; Patel S; Malhotra K; Cullen N; Welck M; Aston W
Foot Ankle Int; 2023 Oct; 44(10):1013-1020. PubMed ID: 37644900
[TBL] [Abstract][Full Text] [Related]
14. Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature.
Verspoor FGM; Mastboom MJL; Weijs WLJ; Koetsveld AC; Schreuder HWB; Flucke U
Int J Oral Maxillofac Surg; 2018 Oct; 47(10):1288-1294. PubMed ID: 29709323
[TBL] [Abstract][Full Text] [Related]
15. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
[TBL] [Abstract][Full Text] [Related]
16. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
Mastboom MJL; Staals EL; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Palmerini E; Schaap GR; Jutte PC; Aston W; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; van de Sande MAJ;
J Bone Joint Surg Am; 2019 Jul; 101(14):1309-1318. PubMed ID: 31318811
[TBL] [Abstract][Full Text] [Related]
17. Severity classification of Tenosynovial Giant Cell Tumours on MR imaging.
Mastboom MJL; Verspoor FGM; Hanff DF; Gademan MGJ; Dijkstra PDS; Schreuder HWB; Bloem JL; van der Wal RJP; van de Sande MAJ
Surg Oncol; 2018 Sep; 27(3):544-550. PubMed ID: 30217317
[TBL] [Abstract][Full Text] [Related]
18. Distraction arthroplasty combined with autologous bone grafting for diffuse-type tenosynovial giant cell tumour with articular cartilage defect and subchondral bone cysts: A case report.
Ikuta Y; Nakasa T; Sumii J; Nekomoto A; Kawabata S; Adachi N
Mod Rheumatol Case Rep; 2023 Jun; 7(2):483-487. PubMed ID: 36484489
[TBL] [Abstract][Full Text] [Related]
19. The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CT.
Mastboom MJL; Lips W; van Langevelde K; Mifsud M; Ng C; McCarthy CL; Athanasou NA; Gibbons CLMH; van de Sande MAJ
Surg Oncol; 2020 Dec; 35():261-267. PubMed ID: 32932224
[TBL] [Abstract][Full Text] [Related]
20. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
